ASCO Conference Coverage
Featured Articles
(Forbes) June 15, 2017 - We need to do more than just raise cancer drug prices yet again. We need to invest in the kind of infrastructure that will make it possible to test many of these medicines, and speed up innovation further.
Read Article
(Medscape Medical News) June 15, 2017 - Results from the long-term follow-up of frontline therapy for patients with indolent non-Hodgkin's lymphoma (iNHL) show the long-term benefits of chemotherapy in combination with rituximab (Rituxan, Roche/Genentech).
Read Article
Latest Articles
August 07, 2017
August 07, 2017
July 11, 2017
June 27, 2017
June 22, 2017
June 22, 2017
June 20, 2017
June 19, 2017
View More
News Commentary
Editor Image
10 Aug, 2017 | by Thomas Marsland, MD
So I usually do not even know the exact cost of the drugs. I believe for me and...
View Comment
Editor Image
16 Jun, 2017 | by Winston Wong, PharmD
There is an infrastructure problem, and the problem is that we need to do a...
View Comment
View More
OBR Blog
By Jay Grisolano, PhD and Stephanie Ritz, PhD Approximately a quarter of breast cancer patients are classified as... Read more
June 05, 2017
By Liseth Parra, Ph.D., and Stephanie Hawthorne, Ph.D.   A very exciting therapeutic area that has been constantly... Read more
June 05, 2017